Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRIME II trial of paracetamol in STEMI
ACTRN12626000027314Phase 4Not yet recruiting
- Sponsor
- Te Whatu Ora
- Start
- Mar 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of acetaminophen in myocardial infarction (MI) and acute ST-segment elevation myocardial infarction (STEMI) (2 arms), sponsored by Te Whatu Ora. Primary endpoint: Average peak troponin level. Planned start Mar 2026; status: not yet recruiting.
02
Drugs
acetaminophen
03
Conditions
myocardial infarction (MI)acute ST-segment elevation myocardial infarction (STEMI)
Beyond the preview
Go deeper on ACTRN12626000027314.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12626000027314.